Our Global Presence

Strategic pharmaceutical reach across South Asia, Southeast Asia, and the CIS region. Partnering for ethical market leadership through technical excellence and regulatory integrity.

Nibblen Presence
India
๐Ÿ‡ฎ๐Ÿ‡ณ Our records in India

India

01

Renucart

Glucosamine sulphate [2 extensions]

Market Authorization
02

Nervex BT

Diabetic nutritional supplement

Market Authorization
03

DEPLUS

Vitamin D [as drug - 2 extensions]

Market Authorization
04

DEPLUS

Vitamin D Drops 400 IU

Market Authorization
05

EMPLUS

Magnesium Supplement

Market Authorization
06

Neuro PEA

food Supplement

Market Authorization

CIN No: U74999TN2017PTC119781 GST number: 33AAFCN8554J1Z5

India
๐Ÿ‡ฎ๐Ÿ‡ณ Our records in India

India

01

Renucart

Glucosamine sulphate [2 extensions]

Market Authorization
02

Nervex BT

Diabetic nutritional supplement

Market Authorization
03

DEPLUS

Vitamin D [as drug - 2 extensions]

Market Authorization
04

DEPLUS

Vitamin D Drops 400 IU

Market Authorization
05

EMPLUS

Magnesium Supplement

Market Authorization
06

Neuro PEA

food Supplement

Market Authorization

CIN No: U74999TN2017PTC119781 GST number: 33AAFCN8554J1Z5

3

Brand Leaders

3+

Extensions

Sri Lanka
๐Ÿ‡ฑ๐Ÿ‡ฐ Regulatory Strategy & Market Authorization

Sri Lanka

01

RENUCART

Glucosamine sulphate [3 extensions]

Brand Leader
RENUCART
02

NERVEX BT

Diabetic nutritional supplement

Brand Leader
NERVEX BT
03

DEPLUS

Vitamin D [as drug โ€“ 4 extensions]

Brand Leader
DEPLUS
04

DEPLUS

Vitamin D Drops 400 IU

Brand Leader
DEPLUS
05

FERT

Joint support solution

Available
FERT
06

ENITAZ

Ornidazole Tablets 500mg

Available
ENITAZ
07

MELOT

Melatonin Tablets 3 mg

Available
MELOT
08

DASEY 10

Serratiopeptidase Tablets 10mg

Available
DASEY 10

26

Products Registered

6

Active Promotions

3

Distributors

Russia
๐Ÿ‡ท๐Ÿ‡บ Our records in Russia

Russia

01

RESVERATROL

Nutritional supplement

Registered
RESVERATROL
02

EFFEVIT

Nutritional supplement

Registered
EFFEVIT
03

MERIK

Joint health support

Registered
MERIK
04

ISOVIN

Nutritional supplement

Registered
ISOVIN
05

BONE FACTOR

Calcium Citrate 200mg, Magnesium 100mg, Zinc 5mg, Vitamin D3 5mcg Tablets

Registered
BONE FACTOR
06

LIV FORTE

Multi-ingredient liver support formulation with herbal extracts.

Registered
LIV FORTE
07

EVENING PRIMROSE OIL

Natural source of GLA for balanced health and wellness.

Registered
EVENING PRIMROSE OIL
08

HEART HEALTH

Comprehensive support for cardiovascular wellness and vitality.

Registered
HEART HEALTH
09

GARCINIA

Metabolism support supplement

Registered

Regulatory Achievements

26 Food Supplement Products Successfully Registered

Strong regulatory compliance and approval track record

Approved

Continuous expansion of product portfolio

Ongoing regulatory submissions and approvals

Ongoing

Marketing & Promotion

6 Products Actively Promoted Across Media Platforms

Strategic brand visibility campaigns

Strategic

Distribution Network

Operating with 3 Established Distributors

Strong supply chain coordination

Operating

Expanding regional footprint and market coverage

Growing distribution reach across the region

Active

6

Launched Products

10

Registered Products

18

In Pipeline

Vietnam
๐Ÿ‡ป๐Ÿ‡ณ Strategic Expansion & Local Establishment

Vietnam

01

LIDOREX

Our Vietnam portfolio features high-performance formulations like this spotlighted product, specifically authorized and selected for the local regional health standards.

Featured Spotlight
LIDOREX
02

TORIX

Relieves pain inflammation

Registered
TORIX
03

ADDE

Nutritional supplement

Registered
ADDE
04

FIZZ

Papain, Fungal Diastase and Simethicone Effervescent Tablets - A specialized formulation for digestive health.

Registered
FIZZ

As part of its continued global expansion and commitment to improving patient access, NIBBLEN successfully established a Representative Office in Ho Chi Minh City, Vietnam.

This strategic milestone reflects our long-term vision of operating in close collaboration with local stakeholders and regulatory authorities. The establishment enhances our Southeast Asian footprint by enabling streamlined operations, stronger regulatory alignment, efficient communication, and dedicated local support for partners and clients.

Registered Products

01Lidorex 1% Inj
02Lidorex 2% Inj
03Toranel 10 Inj
04Toranel 30 Inj
05ADDE Softgel
06Recal Softgel
07Freenee Capsule
08Torix 60 Tablet
09Torix 90 Tablet
10FIZZ Effervescent Tablet

Pipeline & Portfolio Expansion

18

Products in Development

6

Nearing Approval

Therapeutic Areas

  • General Medicine
  • Urology
  • Diabetology
  • Anti-infectives
  • Fertility & Reproductive Health
Myanmar
๐Ÿ‡ฒ๐Ÿ‡ฒ Emerging Market Development

Myanmar

01

LENCOX-60

Effective pharmaceutical solution

Market Authorization
LENCOX-60
02

NELIDE-10

Leflunomide Tablets USP 10mg

Market Authorization
NELIDE-10
03

FENALEN

Fexofenadine HCL Tablets usp 120mg

Market Authorization
FENALEN
04

NOSTHRO

Azithromycin Tablets USP 500mg

Market Authorization
NOSTHRO
05

NOCMOX-228.5

Amoxicillin & Clavulanate Potassium Dry Syrup

Market Authorization
NOCMOX-228.5
06

Lindam 300

Clindamycin Capsules BP 300mg

Market Authorization
Lindam 300
07

Lentricet-1000

Levetiracetam Tablets USP 1000mg

Market Authorization
Lentricet-1000

Myanmar presents promising growth potential with increasing demand for safe and effective pharmaceutical solutions. We have initiated groundwork for product registration, identified therapeutic gaps, and begun establishing partnerships with potential distributors to introduce essential generics and specialty medicines.

Cambodia
๐Ÿ‡ฐ๐Ÿ‡ญ Strategic Market Entry

Cambodia

01

LINDA

Clindamycin Capsules BP 150mg

Market Authorization
LINDA
02

FUCIDE

Fluconazole Tablets USP 200mg

Market Authorization
FUCIDE
03

ABADOL

Gabapentin Capsules USP 300mg

Market Authorization
ABADOL
04

UREPILL

Hydrochlorothiazide Tablets USP 25mg

Market Authorization
UREPILL

Following our success in Vietnam, we are strategically expanding into Cambodia. Our approach focuses on developing strong relationships with local distributors, understanding regulatory requirements, and launching high-quality products aligned with national healthcare priorities.

Uzbekistan
๐Ÿ‡บ๐Ÿ‡ฟ Our records in Uzbekistan

Uzbekistan

01

ะžะ ะขะžะคะ›ะ•ะšะก

Glucosamine supplement for joint health

Registered
ะžะ ะขะžะคะ›ะ•ะšะก
02

URONICE

Prostate health and relieving urinary problems

Registered
URONICE

In Progress

Philippines
๐Ÿ‡ต๐Ÿ‡ญ Market Entry & Commercial Strategy

Philippines

Inprogress

Our Commitment to Healthcare Access

We remain committed to enhancing healthcare access throughout Southeast Asia. Beginning with Vietnam and expanding into Cambodia, Myanmar, and Laos, we're establishing a robust regional footprint supported by regulatory adherence, local collaborations, and a patient-focused strategy.

We aim to deliver high-quality, affordable medicines that address the changing healthcare needs in these developing markets. Through strategic partnerships, ongoing product development, and a committed team, we are confident in our mission to positively influence public health and strengthen our brand across the ASEAN region.

01

Regulatory Adherence

Full compliance with local and international pharmaceutical standards

02

Local Collaborations

Strategic partnerships with regional distributors and health authorities

03

Patient-Focused Strategy

Delivering affordable, high-quality medicines to underserved markets

โ€œ

Positively influencing public health across the ASEAN region through quality medicines and trusted partnerships.